Validation of the systemic lupus erythematosus activity questionnaire in a large observational cohort.
about
Approaches for estimating minimal clinically important differences in systemic lupus erythematosusBurden of systemic lupus erythematosus on employment and work productivity: data from a large cohort in the southeastern United States.Provision of preventive health care in systemic lupus erythematosus: data from a large observational cohort study.Validity of a self-administered version of the brief index of lupus damage in a predominantly African American systemic lupus erythematosus cohort.Health-related quality of life and employment among persons with systemic lupus erythematosus.Longitudinal validation of the Brief Index of Lupus Damage.Health care costs and costs associated with changes in work productivity among persons with systemic lupus erythematosus.Differences in long-term disease activity and treatment of adult patients with childhood- and adult-onset systemic lupus erythematosus.Depression, medication adherence, and service utilization in systemic lupus erythematosusQuality of care in systemic lupus erythematosus: the association between process and outcome measures in the Lupus Outcomes Study.Fibromyalgia, systemic lupus erythematosus (SLE), and evaluation of SLE activity.Hydroxychloroquine treatment in a community-based cohort of patients with systemic lupus erythematosus.Osteoporosis screening, prevention, and treatment in systemic lupus erythematosus: application of the systemic lupus erythematosus quality indicatorsObesity and its measurement in a community-based sample of women with systemic lupus erythematosus.Patient-reported outcome measures for systemic lupus erythematosus clinical trials: a review of content validity, face validity and psychometric performance.Elevated C-reactive protein and self-reported disease activity in systemic lupus erythematosus.Muscle strength, muscle mass, and physical disability in women with systemic lupus erythematosus.Contraceptive counseling and use among women with systemic lupus erythematosus: a gap in health care quality?Brief index of lupus damage: a patient-reported measure of damage in systemic lupus erythematosus.Development and initial validation of a self-assessed lupus organ damage instrumentImpact of obesity on functioning among women with systemic lupus erythematosus.Report of an international symposium on narrowing the Gap in the treatment and study of SLE worldwide: minimum best practices in the management and monitoring of moderate to severe SLE and improving outcomes in constrained environmentsLongitudinal study of the impact of incident organ manifestations and increased disease activity on work loss among persons with systemic lupus erythematosusPhysical activity, obesity, and cognitive impairment among women with systemic lupus erythematosusMuscle Strength and Changes in Physical Function in Women With Systemic Lupus Erythematosus.Quality of care in systemic lupus erythematosus: application of quality measures to understand gaps in care.Factors associated with pain coping and catastrophising in patients with systemic lupus erythematosus: a cross-sectional study of the LuLa-cohortCardiovascular disease and cognitive dysfunction in systemic lupus erythematosus.Cardiovascular and disease-related predictors of depression in systemic lupus erythematosus.Using the Center for Epidemiologic Studies Depression Scale to screen for depression in systemic lupus erythematosus.Childhood-onset disease as a predictor of mortality in an adult cohort of patients with systemic lupus erythematosus.Association of age with health-related quality of life in a cohort of patients with systemic lupus erythematosus: the Georgians Organized Against Lupus study.Frequent use of the emergency department among persons with systemic lupus erythematosus.Genetic risk and longitudinal disease activity in systemic lupus erythematosus using targeted maximum likelihood estimation.Employment and work disability in systemic lupus erythematosus: a systematic review.Lymphoma risk in systemic lupus: effects of disease activity versus treatmentPrevalence of mood and anxiety disorders in women with systemic lupus erythematosus.Is frailty a relevant concept in SLE?A Prospective Study of the Impact of Current Poverty, History of Poverty, and Exiting Poverty on Accumulation of Disease Damage in Systemic Lupus Erythematosus.Components of quality of life in a sample of patients with lupus: a confirmatory factor analysis and Rasch modeling of the LupusQoL.
P2860
Q27021623-84F4948D-FA5C-4F72-BFF4-3B372B9C8566Q30715531-571A1E65-E1B7-4F4B-857F-18F8BCFA5DE2Q33576353-F78C3BB4-C5C8-4850-976B-3FBDEA03807CQ33631028-3D798E37-42CF-46C1-AC59-6A9EAFE3EA24Q33708268-DB87062B-57F4-47D5-8577-BE56094E523EQ33801123-864FC48B-943C-4CF6-AF25-FAA5CCD02D8DQ33871768-A4515919-6F24-4036-9DDB-9795883B1070Q33871944-4642D882-0EB3-4AC0-994D-DD0B4508B771Q33871960-5834798D-5B52-4E9A-9CA6-6134F69EDAFCQ33981158-6762AAA9-1F2C-4528-9577-D9C269D69161Q34149215-74E180EB-4F97-45E1-904D-DEFCA932327CQ34162739-D41B0258-924A-4325-91C5-03DDFCD46B5CQ34192060-E8337129-BA2A-426F-841B-1A69BCB19FDBQ34440634-31D0CD6C-26F6-4990-910F-861194C9318FQ34467966-0651305C-4EF6-481F-82E8-22E401423034Q34518097-75DE4595-418F-42A9-A2F6-C1E57B711AF0Q34791248-226C0AA8-5278-44D0-9767-F0D3531AE40AQ35046602-EB929943-7551-4F06-B6F8-240E964D205DQ35146106-04D261B0-E64F-408E-A5C8-09822B97885CQ35229755-3705624C-B2AA-49A8-A9EC-5F3044F5ADB1Q35243135-6A4BE51F-9AFF-42D3-8B74-FF2EB3F86A1BQ35680662-8397CD6B-C330-4EAA-8200-A9B5A8BC2FA3Q35686616-CFB9EF4B-41C2-4FF4-8D18-C4B7F76902DEQ35861313-21268532-7CC4-4647-A230-3400F618630CQ35890109-6F5CBA9F-82CF-4555-8A71-1522A0C1C489Q36243472-94CE9877-6658-402E-AC52-99841FCD0E13Q36302250-799B6B11-CAA1-4201-BA49-CF0A3F35B9BAQ36995139-AA402C9E-E474-4BF5-B6F3-95E14A8BAA32Q37019825-8CD8A6DC-2708-453B-B9E6-FEA6AB450376Q37036848-8803C5DF-C495-4CA8-8626-A114F7E3F926Q37127464-1EA0C094-4EF8-4504-8789-BEE5CF5506FCQ37133875-8ACE53C6-0E19-4C4E-B6C4-5264A4FC1D62Q37137307-3BB47E54-AF62-43E1-A5E3-FFC8B7D31520Q37227144-D6CD2E4F-446F-4C33-949C-CFB98DFD48BEQ37372208-7F83FD44-40B6-439A-B8AE-5031F90598EDQ37374458-DDFE686E-0224-45A0-B82A-705534CDCB8DQ37391150-D8AD98D2-7DB6-4BDC-8D09-922D7C4529EAQ37627359-7C6CCA19-C6FB-41B2-A349-40A8A2718BE4Q38798890-0092DD94-546F-433E-BAF8-957882724E2FQ38807631-6D372DC1-806D-415F-88E3-4A675284C618
P2860
Validation of the systemic lupus erythematosus activity questionnaire in a large observational cohort.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Validation of the systemic lup ...... a large observational cohort.
@en
Validation of the systemic lup ...... a large observational cohort.
@nl
type
label
Validation of the systemic lup ...... a large observational cohort.
@en
Validation of the systemic lup ...... a large observational cohort.
@nl
prefLabel
Validation of the systemic lup ...... a large observational cohort.
@en
Validation of the systemic lup ...... a large observational cohort.
@nl
P2093
P2860
P356
P1476
Validation of the systemic lup ...... a large observational cohort.
@en
P2093
Edward H Yelin
Jinoos Yazdany
Laura Julian
Laura Trupin
Pantelis Panopalis
Patricia P Katz
P2860
P304
P356
10.1002/ART.23238
P577
2008-01-01T00:00:00Z